Company overview
Basic information
Company name
Gyvastė, MB
Company code
306321261
Registered address
Kauno r. sav., Domeikavos sen., Radikių k., Žemynos g. 14, LT-54381
Registration date
2023-05-18
Company age: 3 y. 5 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Manufacture of medical and dental instruments and supplies
Ownership form
Private without foreign capital
MB "Gyvastė"
Company code: 306321261
Address: Kauno r. sav., Domeikavos sen., Radikių k., Žemynos g. 14, LT-54381
Description
This description was generated by artificial intelligence.
Gyvaste, MB (company code 306321261) is an operational private small partnership registered in 2023. It is classified as a micro-sized entity in the national private non-financial companies sector and is governed by a CEO only structure. The company is privately owned, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Its registered address is Žemynos g. 14, Radikiai village, Domeikava eldership, Kaunas district municipality, Kaunas county.
The company’s activity is coded C.32.50.90 and described as Manufacture of other medical and dental devices, instruments and supplies. Financially, the business generated €7.2K in revenue in 2023, €2.8K in 2024 and €3.0K in 2025. Net profit was €4.6K in 2023, €936 in 2024 and €187 in 2025, with profit margin declining from 63.1% to 33.5% and then to 6.3%. Equity increased from €4.7K to €5.8K over the same period, while liabilities remained very low at €12, €31 and €50. The latest staff year in the dataset is so far in 2026, although no employee or wage figures are provided.
The company’s activity is coded C.32.50.90 and described as Manufacture of other medical and dental devices, instruments and supplies. Financially, the business generated €7.2K in revenue in 2023, €2.8K in 2024 and €3.0K in 2025. Net profit was €4.6K in 2023, €936 in 2024 and €187 in 2025, with profit margin declining from 63.1% to 33.5% and then to 6.3%. Equity increased from €4.7K to €5.8K over the same period, while liabilities remained very low at €12, €31 and €50. The latest staff year in the dataset is so far in 2026, although no employee or wage figures are provided.
Download a detailed company report
Make confident decisions with all the information about Gyvastė, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.